Omalizumab use during pregnancy for CIU: a tertiary care experience.
نویسندگان
چکیده
The treatment of antihistamine and steroid resistant Chronic Idiopathic Urticaria (CIU) during pregnancy poses a challenge due to teratogenicity of immunosuppressants. Omalizumab is a recently FDA approved therapy for CIU and is classified as pregnancy category B. We present an initial series of subjects treated at a tertiary care center for antihistamine and steroid resistant CIU with omalizumab who became pregnant during therapy.
منابع مشابه
Cost-Effectiveness of Omalizumab in Chronic Idiopathic Urticaria Refractory to H1-Antihistamines in Turkey.
PSS3 CoSt-EffECtivEnESS of omalizumab in ChroniC idioPathiC urtiCaria rEfraCtory to h1-antihiStaminES in turkEy Tatar M.1, Sezen S.2, Senturk A.3, Balp M.M.4, Saylan M.2, Keskinaslan A.2 1Hacettepe University, Ankara, Turkey, 2Novartis Pharma, Istanbul, Turkey, 3Polar Polar Health Economics & Policy, Ankara, Turkey, 4Novartis Pharma AG, Basel, Switzerland Objectives: Omalizumab is a humanised a...
متن کاملXolair® (omalizumab) enrollment in a tertiary care allergy and asthma clinic in Canada
Background Xolair ® (omalizumab) has been approved in Canada since 2004 for the treatment of moderate to severe persistent allergic asthma in patients 12 years of age. The use of omalizumab in severe persistent allergic asthma may lead to decrease health care utilization through emergency room (ER) visits, hospitalizations, visits to health care providers, as well as, decrease the use of cortic...
متن کاملEfficacy and Safety of Omalizumab in Patients with Chronic Idiopathic/Spontaneous Urticaria Who Remain Symptomatic on H1 Antihistamines: A Randomized, Placebo-Controlled Study
ASTERIA I was a 40-week, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of subcutaneous omalizumab as add-on therapy for 24 weeks in patients with chronic idiopathic urticaria/spontaneous urticaria (CIU/CSU) who remained symptomatic despite H1 antihistamine treatment at licensed doses. Patients aged 12-75 years with CIU/CSU who remained symptomatic despit...
متن کاملA Brief Report on Telerehabilitation during COVID-19 Outbreak- Experience at a Tertiary Care Center in Kerala
The unanticipated lockdown following the COVID-19 has had a significant impact in the field of rehabilitation compelling the professionals to switch to tele-mode in order to continue service without interruption. The aim of this article is to highlight the steps taken to overcome the various challenges encountered and to strengthen the opportunities in telerehabilitation services at a tertiary ...
متن کاملChronic idiopathic urticaria: treatment with omalizumab.
Chronic idiopathic urticaria (CIU) is a common autoimmune skin condition characterized by spontaneously recurring hives for 6 weeks or longer. The new terminology used for CIU in most countries including Canada is chronic spontaneous urticaria (CSU). CSU is associated with significant psychosocial morbidity with a markedly negative impact on overall quality of life. Conventional approaches with...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- European annals of allergy and clinical immunology
دوره 48 4 شماره
صفحات -
تاریخ انتشار 2016